MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation C Alessandria, O Ozdogan, M Guevara, T Restuccia, W Jiménez, V Arroyo, ... Hepatology 41 (6), 1282-1289, 2005 | 491 | 2005 |
Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study N Tozun, O Ozdogan, Y Cakaloglu, R Idilman, Z Karasu, U Akarca, ... Clinical Microbiology and Infection 21 (11), 1020-1026, 2015 | 389 | 2015 |
The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology J Trebicka, J Fernandez, M Papp, P Caraceni, W Laleman, C Gambino, ... Journal of hepatology 73 (4), 842-854, 2020 | 337 | 2020 |
Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study T Restuccia, R Ortega, M Guevara, P Ginès, C Alessandria, O Ozdogan, ... Journal of Hepatology 40 (1), 140-146, 2004 | 326 | 2004 |
Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease Y Yilmaz, F Eren, O Yonal, R Kurt, B Aktas, CA Celikel, O Ozdogan, ... European journal of clinical investigation 40 (10), 887-892, 2010 | 227 | 2010 |
Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease Y Yilmaz, O Yonal, R Kurt, YO Alahdab, F Eren, O Ozdogan, CA Celikel, ... Scandinavian journal of gastroenterology 46 (1), 91-97, 2011 | 176 | 2011 |
Noninvasive assessment of liver fibrosis with the aspartate transaminase to platelet ratio index (APRI): Usefulness in patients with chronic liver disease: APRI in chronic … Y Yilmaz, O Yonal, R Kurt, M Bayrak, B Aktas, O Ozdogan Hepatitis monthly 11 (2), 103, 2011 | 133 | 2011 |
A NATIONWIDE PREVALENCE STUDY AND RISK FACTORS FOR HEPATITIS A, B, C AND D INFECTIONS IN TURKEY: 789 N Tozun, OC Ozdogan, Y Cakaloglu, R Idilman, Z Karasu, US Akarca, ... Hepatology 52, 697A, 2010 | 133 | 2010 |
Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: association with liver fibrosis Y Yilmaz, YO Alahdab, O Yonal, R Kurt, AE Kedrah, CA Celikel, ... Metabolism 59 (9), 1327-1330, 2010 | 127 | 2010 |
Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease B Aktas, Y Yilmaz, F Eren, O Yonal, R Kurt, YO Alahdab, CA Celikel, ... Metabolism 60 (4), 544-549, 2011 | 112 | 2011 |
Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: association with liver fibrosis Y Yilmaz, R Kurt, O Yonal, N Polat, CA Celikel, A Gurdal, H Oflaz, ... Atherosclerosis 211 (1), 182-186, 2010 | 110 | 2010 |
Serum fetuin A/α2HS-glycoprotein levels in patients with non-alcoholic fatty liver disease: relation with liver fibrosis Y Yilmaz, O Yonal, R Kurt, F Ari, AY Oral, CA Celikel, S Korkmaz, ... Annals of Clinical Biochemistry 47 (6), 549-553, 2010 | 80 | 2010 |
Melatonin ameliorates methionine‐and choline‐deficient diet‐induced nonalcoholic steatohepatitis in rats V Tahan, O Atug, H Akin, F Eren, G Tahan, O Tarcin, H Uzun, O Ozdogan, ... Journal of pineal research 46 (4), 401-407, 2009 | 66 | 2009 |
Cytokeratin-18 fragments and biomarkers of the metabolic syndrome in nonalcoholic steatohepatitis Y Yilmaz, AE Kedrah, O Ozdogan World Journal of Gastroenterology: WJG 15 (35), 4387, 2009 | 51 | 2009 |
Serum levels of osteoprotegerin in the spectrum of nonalcoholic fatty liver disease Y Yilmaz, O Yonal, R Kurt, AY Oral, F Eren, O Ozdogan, F Ari, CA Celikel, ... Scandinavian journal of clinical and laboratory investigation 70 (8), 541-546, 2010 | 50 | 2010 |
Prevalence of hepatic granulomas in chronic hepatitis B V Tahan, R Ozaras, N Lacevic, E Ozden, M Yemisen, O Ozdogan, A Mert, ... Digestive diseases and sciences 49, 1575-1577, 2004 | 49 | 2004 |
Effect of Helicobacter pylori eradication on anti‐thrombotic dose aspirin‐induced gastroduodenal mucosal injury A Giral, O ÖZDOGAN, CA Celikel, N TÖZÜN, NB Ulusoy, C Kalayci Journal of gastroenterology and hepatology 19 (7), 773-777, 2004 | 45 | 2004 |
Serum levels of adipokines in patients with chronic HCV infection: relationship with steatosis and fibrosis A Tiftikci, O Atug, Y Yilmaz, F Eren, FT Ozdemir, S Yapali, O Ozdogan, ... Archives of Medical Research 40 (4), 294-298, 2009 | 43 | 2009 |
Causes and risk factors for liver injury following bone marrow transplantation O Özdogan, S Ratip, Y Al Ahdab, F Dane, H Al Ahdab, N Iÿmeryüz, ... Journal of clinical gastroenterology 36 (5), 421-426, 2003 | 43 | 2003 |
Dipeptidyl peptidase IV inhibitors: therapeutic potential in nonalcoholic fatty liver disease Y YilmazABDEFG, O AtugDEF, O YonalEF, D DumanADE, O OzdoganD, ... Med Sci Monit 15 (4), 5, 2009 | 41 | 2009 |